Vertex Pharmaceuticals Inc

NASDAQ: VRTX
$445.21
+$4.57 (+1.0%)
Closing price May 17, 2024

VRTX Articles

Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
While these eight stocks are not being touted as Credit Suisse's formal top picks for 2018, the timeline sure sets them up to be among the top contenders.
The top analyst upgrades, downgrades and other research calls include American Airlines, Boeing, Cabot Oil & Gas, Pandora Media, Southern Co. and Vertex Pharmaceuticals.
Wednesday was a relatively positive day for the U.S. broad markets with green arrows across the board with a few exceptions. Crude oil was up again, but this time Oil & Gas stocks responded very...
Shares of Vertex Pharmaceuticals shot up after the company announced dramatic results from its early and mid-stage trials in cystic fibrosis. The stock pushed to an all-time high on the back of these...
Stocks were indicated to open only slightly higher on Wednesday after a mixed bag of corporate earnings. What investors need to understand is that the major equity indexes remain just under all-time...
The top analyst upgrades, downgrades and other research calls from Tuesday include Agilent, Apple, Citigroup, Exxon, M&T Bank, Snap, Toyota and Twitter.
Many on Wall Street feel that some of the more speculative institutional tech money may be rotating into the biotechs, and with good reason.
The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences and Oracle.
The top analyst upgrades, downgrades and other research calls from Friday include Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty and Yum China.
In Wednesday’s session the markets were largely negative with major money center banks leading the charge down, other investment houses were negative as well. Although crude oil pushed much lower,...
Jefferies analysts remain reasonably bullish, and in their top growth picks for the week the firm focuses on some stocks that could be top momentum stories for the second quarter.
The first quarter's top-performing stocks in the S&P 500 index included two pharmaceutical firms, an electricity generator, a video game maker and a media company.
March 29, 2017: The S&P 500 closed higher on the day, up 0.11 % and 2.56 points to 2,361.14. Separately the DJIA closed down 0.20% on the day at 20,659.39, down approximately 42.11 points. The...